Lewy body disease

Three well-differentiated clinical subtypes within dementia with Lewy bodies

by
Lewy Body profiles - Morenas-Rodriguez - Sant Pau Memory Unit - Barcelona

Dementia with Lewy bodies is a disease with a large clinical heterogeneity in which both symptoms and evolution can vary widely among patients. This clinical heterogeneity is linked to the great neuropathological variability found in autopsy. The Sant Pau Memory Unit of Hospital Sant Pau is a pioneer in the publication of the first study … Read more

Translational Research

by

The multidisciplinary nature of the Sant Pau Memory Unit has favored the development of translational research lines that aim to bridge the gap between bench and clinic. Consequently, many of the results from these research lines have an immediate impact on clinical practice. Biomarkers This research line is focused on the identification and characterization of … Read more

SPIN cohort

by
Volunteer - Sant Pau Memory Unit - Alzheimer Research - Barcelona

Sant Pau Initiative on Neurodegeneration 1. What is the SPIN cohort? The main objective of the SPIN cohort (Sant Pau Initiative on Neurodegeneration) is to widen our knowledge of neurodegenerative diseases such as Alzheimer’s disease, Lewy body dementia and frontotemporal lobe degeneration, through the study of biochemical and neuroimaging markers (also known as biomarkers). This … Read more

Molecular Genetics

by

Our Molecular Genetics Unit is focused on understanding the genetic causes underlying neurodegenerative disorders, and developing new genetic-based biomarkers to aid in disease diagnosis and prognosis. To accomplish this, we use state-of-the-art genetic tools such as next-generation sequencing, ddPCR, etc. applied to patients that have been diagnosed and followed-up by our memory clinic team. We … Read more

Neuroimage

by
Neuroimage - Sant Pau Memory Unit - Alzheimer Research - Barcelona

The neuroimaging group, led by Dr. Alexandre Bejanin, is a multidisciplinary clinical and research team studying neurodegenerative disorders through a wide range of neuroimaging measures. The group has extensive experience with using structural magnetic resonance imaging (MRI), diffusion (DTI) and functional MRI (fMRI), but also positron emission tomography (PET) techniques to detect neurodegeneration and Alzheimer’s … Read more